PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Jun-2022 武田在ASCO和EHA上展示腫瘤學產品組合和研發產品線的最新研究成果 Businesswire
01-Jun-2022 武田在ASCO和EHA上展示肿瘤学产品组合和研发产品线的最新研究成果 Businesswire
01-Jun-2022 Virios Therapeutics’ Study Featured in Peer-Reviewed Journal Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders, Including in Patients with Comorbid Fibromyalgia Businesswire
01-Jun-2022 BELLUS Health to Participate in the Jefferies Healthcare Conference Businesswire
01-Jun-2022 Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference Businesswire
01-Jun-2022 Late-Breaking Data at EULAR 2022 Demonstrate Deucravacitinib Significantly Improved Disease Activity in Phase 2 PAISLEY Study in Systemic Lupus Erythematosus Businesswire
01-Jun-2022 KalVista Pharmaceuticals to Present at 13th Annual Jefferies Healthcare Conference Businesswire
01-Jun-2022 Almac Discovery nominates a first candidate molecule from its Protein Drug Conjugate (PDC) Platform to progress into pre-clinical development Almac Discovery
01-Jun-2022 Amolyt Pharma Announces Positive Results from First Patient Cohort of Phase 2a Trial of AZP-3601 for the Treatment of Hypoparathyroidism Amolyt Pharma
01-Jun-2022 Vetter Publishes First Sustainability Report B3C newswire
01-Jun-2022 ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates ProQR Therapeutics N.V.
01-Jun-2022 HUTCHMED Announces TAZVERIK® Approved to be Used in Hainan Pilot Zone in China HUTCHMED
01-Jun-2022 Florence raises $35 million (£28.5m) to revolutionise social care staffing Florence
01-Jun-2022 Global Pharmaceutical Logistics Market Analysis Report 2022: Robust Demand for Pharmaceutical Logistics Amid the Covid-19 Pandemic Globally - ResearchAndMarkets.com Businesswire
01-Jun-2022 JYSELECA®▼ (filgotinib) recommended by NICE for use in patients with Ulcerative Colitis (UC) Galapagos Biotech LTD
01-Jun-2022 Asgard Therapeutics Granted U.S. Patent for Dendritic Cell Reprogramming Asgard Therapeutics AB
01-Jun-2022 Sage Therapeutics and Biogen Announce that the Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression Met its Primary and All Key Secondary Endpoints Businesswire
01-Jun-2022 AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook Businesswire
01-Jun-2022 Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference Businesswire
01-Jun-2022 Amanda Newton appointed to lead RWS’s Strategic Solutions Group Businesswire